Overall, 2018 showed favorable trends for opioid use with declines in both utilization and cost. Understanding the top opioid medications being filled and impacting spend can help guide decision-making and aid in identifying opportunities for intervention particularly through formulary controls, utilization management strategies, and through insight into regulatory changes and juris-specific rule application. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Business Insurance: Lack of guidelines complicates COVID-19 care
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an
Workers' Comp
Blog
Look for a Broken Spirit, Not Just a Broken Bone
As featured on the workcompwire.com blog, this piece was contributed by Tammy Bradly, Vice President, Clinical Product Develo
Mitchell
News Release
FDA Approves Veklury (Remdesivir) for Treatment of Hospitalized COVID-19 Patients
On October 22, 2020, the Food and Drug Administration (FDA)
Workers' Comp
Case Study
A Higher Calling
Catastrophic Case Management Meet Stephanie, CCM, RN Catastrophic case managers must be equipped t
Workers' Comp
Virtual Event
National Comp Virtual Conference and Ongoing Digital Series
On-Demand
The National Comp Virtual Conference and Ongoing Digital Series w
Workers' Comp
Blog
Expertise and a Strong Specialty Network are Critical in Helping Injured Workers Recover from Opioid Use Disorder
What’s become clear from years of combating opioid use disorders is that, for most patients, recovery is difficult and often